Atlas Trials

Observational Study of Effectiveness and Tolerability of Gliclazide MR 60mg in Diabetic Patients Fasting During RAMADAN

Clinical trial NCT04132934 · COMPLETED

Trial details

NCT number
NCT04132934
Sponsor
Servier Affaires Médicales
Status
COMPLETED
Study type
OBSERVATIONAL
Type 2 Diabetes
Start date
2019-03-11
Primary completion
2019-10-04
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.